These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25031869)

  • 1. Incidental intrathecal injection of meglumine diatrizoate.
    Masjedi M; Khosravi A; Sabetian G; Rahmanian MR
    Iran Red Crescent Med J; 2014 May; 16(5):e9661. PubMed ID: 25031869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal complications after myelography with meglumine diatrizoate.
    Hilz MJ; Huk W; Schellmann B; Sörgel F; Druschky KF
    Neuroradiology; 1990; 32(1):70-3. PubMed ID: 2333138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inadvertent intraoperative myelography with Hypaque: case report and discussion.
    Killeffer JA; Kaufman HH
    Surg Neurol; 1997 Jul; 48(1):70-3. PubMed ID: 9199689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ascending tonic-clonic seizure syndrome in a dog following inadvertent intrathecal use of ionic contrast agent.
    Finke MD; Meola SD; Mazzaferro EM
    J Vet Emerg Crit Care (San Antonio); 2012 Aug; 22(4):488-93. PubMed ID: 22809214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EPIDURAL MYELOGRAPHY WITH WATER-SOLUBLE CONTRAST MATERIAL ("UROGRAFIN").
    YATES DA
    Ann Phys Med; 1965 Aug; 8():81-5. PubMed ID: 14337046
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of intrathecal injection of diatrizoate on dopamine receptors.
    Lasser EC; Lamkin GE
    Acad Radiol; 2002 Jul; 9(7):826-9. PubMed ID: 12139101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inadvertent intrathecal use of ionic contrast media for myelography.
    Bøhn HP; Reich L; Suljaga-Petchel K
    AJNR Am J Neuroradiol; 1992; 13(6):1515-9. PubMed ID: 1442425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Product selection criteria for intravascular ionic contrast media.
    Swanson DP; Dick TJ; Simms SM; Thrall JH
    Clin Pharm; 1985; 4(5):527-38. PubMed ID: 3902331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity of metrizamide and meglumine iocarmate in the spinal subarachnoid space. An experimental study in rats with special reference to long-term effects.
    Skalpe IO; Torvik A
    Invest Radiol; 1975; 10(2):154-9. PubMed ID: 1116932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple 1H NMR spectroscopic method for assay of salts of the contrast agent diatrizoate in commercial solutions.
    Hanna GM; Lau-Cam CA
    J AOAC Int; 1996; 79(4):833-8. PubMed ID: 8757438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of metrizamide from the spinal subarachnoid space: a study of patients with abolished intracranial circulation.
    Eldevik OP
    AJNR Am J Neuroradiol; 1983; 4(3):585-7. PubMed ID: 6410802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inadvertent intrathecal administration of ionic contrast medium to a dog.
    Roux FA; Deschamps JY
    Vet Radiol Ultrasound; 2007; 48(5):414-7. PubMed ID: 17899973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of iohexol 300 and diatrizoate meglumine 60 for body CT: image quality, adverse reactions, and aborted/repeated examinations.
    Bernardino ME; Fishman EK; Jeffrey RB; Brown PC
    AJR Am J Roentgenol; 1992 Mar; 158(3):665-7. PubMed ID: 1739017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic and electrocardiographic effects in man of a new nonionic contrast agent (iohexol): advantages over standard ionic agents.
    Mancini GB; Bloomquist JN; Bhargava V; Stein JB; Lew W; Slutsky RA; Shabetai R; Higgins CB
    Am J Cardiol; 1983 Apr; 51(7):1218-22. PubMed ID: 6837464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accidental Intrathecal Injection of Ionic Contrast: Case Report and Review of the Literature.
    Hudson JS; Abode-Iyamah K; Nagahama Y; Reddy CG
    World Neurosurg; 2017 Jan; 97():757.e1-757.e9. PubMed ID: 27765719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of iohexol and diatrizoate-meglumine in children undergoing cardiac catheterization.
    Pelech AN; Allard SM; Hurd RT; Giddins NG; Collins GF
    Invest Radiol; 1991 Jul; 26(7):665-70. PubMed ID: 1885274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a rapid injection into the canine superior mesenteric artery of diatrizoate meglumine and diatrizoate sodium (Renografin-76).
    Jacobson ED; Eldon C; Fondacaro JD
    Cardiovasc Intervent Radiol; 1980; 3(3):159-62. PubMed ID: 7407811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accidental intrathecal injection of ionic water-soluble contrast medium: report of a case, including treatment.
    Salvolini U; Bonetti MG; Ciritella P
    Neuroradiology; 1996 May; 38(4):349-51. PubMed ID: 8738094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical application of oral meglumine diatrizoate esophagogram in screening esophageal fistula during radiotherapy for esophageal cancer.
    Geng L; Wu R; Hu H; Zhao Y; Fan L; Zhao Z; Liao D; Li M; Xiang M; Ma Y; Du X
    Medicine (Baltimore); 2018 May; 97(18):e0668. PubMed ID: 29718892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent mortality involving convulsions due to subarachnoid Urografin® injection in rats.
    Shimada R; Ezaki J; Kibayashi K
    Leg Med (Tokyo); 2017 Nov; 29():29-33. PubMed ID: 29017086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.